FK506 and the role of immunophilins in nerve regeneration

Molecular Neurobiology

Volumn 15, Issue 3, 1997, Pages 285-306

  Gold, Bruce G ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Calcineurin; Cyclosporin A; FK506; FKBP 12; Glucocorticoid receptor; Immunophilin; Immunosuppressant; Nerve regeneration

Indexed keywords

CALCINEURIN; CALCIUM CHANNEL; CARRIER PROTEIN; DNA BINDING PROTEIN; FK 506 BINDING PROTEIN; HEAT SHOCK PROTEIN; IMMUNOSUPPRESSIVE AGENT; TACROLIMUS;

ANIMAL; CELL CULTURE; DRUG ANTAGONISM; DRUG APPROVAL; DRUG EFFECT; HUMAN; INJURY; METABOLISM; NERVE CRUSH; NERVE FIBER; NERVE REGENERATION; PHYSIOLOGY; REVIEW; SCIATIC NERVE;

ANIMALS; AXONS; CALCINEURIN; CALCIUM CHANNELS; CARRIER PROTEINS; CELLS, CULTURED; DNA-BINDING PROTEINS; DRUG APPROVAL; HEAT-SHOCK PROTEINS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; NERVE CRUSH; NERVE REGENERATION; SCIATIC NERVE; TACROLIMUS; TACROLIMUS BINDING PROTEINS;

EID: 0031309575     PISSN: 08937648     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02740664     Document Type: Article

References (170)

1. Abe K., Chu P.-J., Ishihara A., and Saito H. (1996) Transforming growth factor-β1 promotes reelongation of injured axons of cultured rat hippocampal neurons. Brain Res. 723, 206-209.
2. Alnemri E. S., Fernandes-Alnemri T., Nelki D. S., Dudley K., DuBois G. C., and Litwack G. (1993) Overexpression, characterization, and purification of a recombinant mouse immunophilin FKBP-52 and identification of an associated phosphoprotein. Proc. Natl. Acad. Sci. USA 90, 6839-6843.
3. Angelov D. N., Neiss V. F., Streppel M., Andermahr J., Mader K., and Stennert E. (1996) Nimodipine accelerates axonal sprouting after surgical repair of rat facial nerve. J. Neurosci. 16, 1041-1048.
4. Armistead D. M., Badia M. C., Deininger D. D., Duffy J. P., Saunders J. O., Tung R. D., Thomson J. A., DeCenzo M. T., Futer O., Livingston D. J., Murcko M. A., Yamashita M. M., and Navia M. A. (1995) Design, synthesis and structure of non-macrocyclic inhibitors of FKBP12, the major binding protein for the immunosuppressant FK506. Acta Cryst. 51, 522-528.
5. Bächinger H. P., Morris N. P., and Davis J. M. (1993) Thermal stability and folding of the collagen triple helix and the effects of mutations in osteogenesis imperfecta on the triple helix of type I collagen. Am. J. Med. Genet. 45, 152-162.
6. Banker G. A. and Cowan W. M. (1977) Rat hippocampal neurons in dispersed cell culture. Brain Res. 126, 397-425.
7. Batchelor M. J., Gillespie R. J., Golec J. M. C., Hedgecock C. J. R., Jones S. D., and Murdoch R. (1994) Total synthesis of close analogues of the immunosuppressant FK506. Tetrahedron 50, 809-825.
8. Baughman G., Wiederrecht G. J., Campbell N. F., Martin M. M., and Bourgeois S. (1995) FKBP51, a novel T-cell-specific immunophilin capable of calcineurin inhibition. Mol. Cell Biol. 15, 4395-4402.
9. Bennett P. C., Zhao W., Lawen A., and Ng K. T. (1996) Cyclosporin A, an inhibitor of calcineurin, impairs memory formation in day-old chicks. Brain Res. 730, 107-117.
10. Beuche W. and Friede R. L. (1984) The role of non-resident cells in Wallerian degeneration. J. Neurocytol. 13, 767-796.
11. Bierer B. E., Somers P. K., Wandless T. J., Burakoff S. J., and Schreiber S. L. (1990) Probing immunosuppressant action with a nonnatural immunophilin ligand. Science 250, 556-559.
12. Bijlsma W. A., Jennekens W. A., Schotman P., and Gispen W. H. (1984) Neurotrophic factors and regeneration in the peripheral nervous system. Psychoneuroendocrinology 9, 199-215.
13. Bijlsma W. A., Jennekens F. G. I., Schotman P., and Gispen W. H. (1983) Stimulation of ACTH4-10 of nerve fiber regeneration following sciatic nerve crush. Muscle Nerve 6, 104-112.
14. Bijlsma W. A., Jennekens F. G. I., Schotman P., and Gispen W. H. (1981) Effects of corticotrophin (ACTH) on recovery of sensorimotor function in the rat: structure-activity study. Eur J. Pharmacol. 76, 73-79.
15. Bixby J. L. and Jhabvala P. (1993) Tyrosine phosphorylation in early embryonic growth cones. J. Neurosci. 13, 3421-3432.
16. Brück W. and Friede R. L. (1990) Anti-macrophage CR3 antibody blocks myelin phagocytosis by macrophages in vitro. Acta Neuropath. 103, 182-187.
17. Brillantes A. M. B., Ondrias K., Scott A., Kobrinsky E., Ondriasova E., Moschella M. C., Jayaraman T., Landers M., Ehrlich B. E., and Marks A. R. (1994) Stabilization of calcium release channel (ryanodine receptor) function by FK506-binding protein. Cell 77, 513-523.
18. Bronster D. J., Yonover P., Stein J., Scelsa S. N., Miller C. M., and Sheiner P. A. (1995) Demyelinating sensorimotor polyneuropathy after administration of FK506. Transplantation 59, 1066-1068.
19. Butcher S. P., Henshall D. C., Teramura Y., Iwasaki K., and Sharkey J. (1997) Neuroprotective actions of FK506 in experimental stroke: in vivo evidence against an anti-excitotoxic mechanism. J. Neurosci. 17, 6939-6946.
20. Cameron A. M., Steiner J. P., Sabatini D. M., Kaplin A. I., Walensky L. D., and Snyder S. H. (1995a) Immunophilin FK506 binding protein associated with inositol 1,4,5-trisphosphate receptor modulates calcium flux. Proc. Natl. Acad. Sci. USA 92, 1784-1788.
21. 2+ flux. Cell 83, 463-472.
22. Cardenas M. E., Zhu D., and Heitman J. (1995) Molecular mechanisms of immunosuppression by cyclosporine, FK506, and rapamycin. Curr. Opin. Nephrol. Hypertens. 4, 472-477.
23. Chang H. Y., Takei K., Sydor A. M., Born T., Rusnak F., and Jay D. G. (1995) Asymmetric retraction of growth cone filopodia following focal inactivation of calcineurin. Nature 376, 686-690.
24. Charng M.-J., Kinnunen P., Hawker J., Brand T., and Schneider M. D. (1996) FKBP-12 recognition is dispensable for signal generation by type I transforming growth factor-β receptors. J. Biol. Chem. 271, 22941-22944.
25. Chen S. and Bisby M. A. (1993) Impaired motor axon regeneration in the C57BL/Ola mouse. J. Comp. Neurol. 333, 449-454.
26. Compton L. A., Davis J. M., MacDonald J. R., and Bachinger H. P. (1992) Structural and function characterization of Escherichia coli peptidyl-prolyl cis-trans isomerases. Eur. J. Biochem. 206, 927-934.
27. Contreras P. C., Steffler C., Yu E., Callison K., Stong D., and Vaught J. L. (1995) Systemic administration of rhIGF-I enhanced regeneration after sciatic nerve crush in mice. J. Pharmacol. Exp. Ther. 274, 1443-1449.
28. Cosenza C. A., Cramer D. V., and Makowka L. (1994) The use of immunosuppressive agents in animal models of experimental transplantation, in Handbook of Animal Models in Transplantation Research (Cramer D. V., Posesta L., and Makowka L. eds.), CRC Press, Boca Raton, FL, pp. 331-337.
29. Czar M. J., Owens-Grillo J. K., Yem A. W., Leach K. L., Deibel M. R., Jr., Welsh M. J., and Pratt W. B. (1994) The hsp56 immunophilin component of untransformed steroid receptor complexes is localized both to microtubules in the cytoplasm and to the same nonrandom regions within the nucleus as the steroid receptor. Mol. Endocrin. 8, 1731-1741.
30. Dawson T. M., Steiner J. P., Dawson V. L., Dinerman J. L., Uhl G. R., and Snyder S. H. (1993) Immunosuppressant FK506 enhances phosphorylation of nitric oxide synthase and protects against glutamate neurotoxicity. Proc. Natl. Acad. Sci. USA 90, 9808-9812.
31. De Koning P. and Gispen W. H. (1987a) A rationale for the use of melanocortins in neural damage, in Pharmacological Approaches to the Treatment of Brain and Spinal Cord Injury (Stein D. G. and Sabel G., eds.), Plenum, New York, pp. 233-258.
32. De Koning P. and Gispen W. H. (1987b) Org. 2766 improves functional and electrophysiological aspects of regenerating sciatic nerve in the rat. Peptides 8, 415-422.
33. Diamond J., Foerster A., Holmes M., and Coughlin M. (1992) Sensory nerves in adult rats regenerate and restore sensory function to the skin independently of endogenous NGF. J. Neurosci. 12, 1467-1476.
34. Drake M., Friberg H., Boris-Möller F., Sakata K., and Wieloch T. (1996) The immunosuppressant FK506 ameliorates ischaemic damage in the rat brain. Acta Physiol. Scand. 158, 155-159.
35. Dumont F. J., Staruch M. J., Koprak S. L., Siekierka J. J., Lin C. S., Harrison R., Sewell T., Kindt V. M., Beattie T. R., Wyvratt M., and Sigal N. H. (1992) The immunosuppressive and toxic effects of FK-506 are mechanistically related: pharmacology of a novel antagonist of FK-506 and rapamycin. J. Exp. Med. 176, 751-760.
36. 4-10 on protein synthesis, actin and tubulin during regeneration. Brain Res. Bull. 15, 267-272.
37. Ekström P. A. R. and Tomlinson D. R. (1990) Impaired nerve regeneration in streptozotocin-diabetic rats is improved by treatment with gangliosides. Exp. Neurol. 109, 200-203.
38. Ekström P. A. R., Kanje M., and Skottner A. (1989) Nerve regeneration and serum levels of insulin-like growth factor-I in rats with streptozotocin-induced insulin deficiency. Brain Res. 496, 141-147.
39. Figueras A., Morales-Olivas F. J., and Capella D. (1992) Bovine gangliosides and acute motor polyneuropathy. Brit. Med. J. 305, 1330-1331.
40. Freman D. A., Klee C. B., Bierer B. E., and Burakoff S. J. (1992) Calcineurin phosphatase activity in T lymphocytes is inhibited by FK506 and cyclosporin A. Proc. Natl. Acad. Sci. USA 89, 3686-3690.
41. Friede R. L. and Brück W. (1993) Macrophage functional properties during myelin degradation. Adv. Neurol. 59, 327-336.
42. Funauchi M., Haruta H., and Tsumoto T. (1994) Effects of an inhibitor for calcium/calmodulin-dependent protein phosphatase, calcineurin, on induction of long-term potentiation in rat visual cortex. Neurosci. Res. 19, 269-278.
43. Fung J. J., Eliasziw M., Todo S., Jain A., Demetris A. J., McMichael J. P., Starzl T. E., Meier P., and Donner A. (1996) The Pittsburgh randomized trial of tacrolimus compared to cyclosporine for hepatic transplantation. J. Am. Coll. Surg. 183, 117-125.
44. Gallai V., Mazzotta G., Montesi S., Sarchielli P., and Del Gatto F. (1992) Effects of uridine in the treatment of diabetic neuropathy: an electrophysiological study. Acta Neurol. Scand. 86, 3-7.
45. Giannini G., Conti A., Mammarella S., Scrobogna M., and Sorrentino V. (1995) The ryanodine receptor/calcium channel genes are widely and differentially expressed in murine brain and peripheral tissues. J. Cell Biol. 128, 893-904.
46. 2+ antagonist nimodipine and recovery of function following peripheral nerve damage in the rat. Neurosci. Res. Commun. 8, 175-184.
47. Gold B. G. (1997) Axonal regeneration of sensory neurons is delayed by continous intrathecal infusion of nerve growth factor. Neuroscience 76, 1153-1158.
48. Gold B. G., Zeleny-Pooley M., Wang M.-S., Chaturvedi P., and Armistead D. M. (1997) A non-immunosuppressant FKBP-12 ligand increases nerve regeneration. Exp. Neurol. 147, 269-278.
49. Gold B. G., Katoh K., and Storm-Dickerson T. (1995) The immunosuppressant FK506 increases the rate of axonal regeneration in rat sciatic nerve. J. Neurosci. 15, 7505-7516.
50. Gold B. G., Storm-Dickerson T., and Austin D. R. (1994) The immunosuppressant FK506 increases functional recovery and nerve regeneration following peripheral nerve injury. Restor. Neurol. Neurosci. 6, 287-296.
51. Gold B. G., Storm-Dickerson T., Austin D. R., and Katoh K. (1993) FK506, an immunosuppressant, increases functional recovery and axonal regeneration in the rat following axotomy of the sciatic nerve. Soc. Neurosci. Abstr. 19, 1316.
52. Goldberger M. M., Murray M., and Tessler A. (1993) Sprouting and regeneration in the spinal cord: Their roles in recovery of function after spinal injury, in Neuroregeneration (Gorio A., ed.), Raven, New York, pp. 241-264.
53. Gorio A., DiGiulio A. M., and Mantegazza P. (1993) Pharmacology of neuronal regeneration, in Neuroregeneration (Gorio A., ed.), Raven, New York, pp. 289-320.
54. Goto S. and Singer W. (1994) Laminar and columnar organization of immunoreactivity for calcineurin, a calcium- and calmodulin-regulated protein phosphatase, in monkey striate cortex. Cereb. Cortex 4, 636-645.
55. Griffin J. W., George R., and Ho T. (1993) Macrophage systems in peripheral nerves: a review. J. Neuropathol. Exp. Neurol. 52, 553-560.
56. Griffith J. P., Kim J. L., Kim E. E., Sintchank M. D., Thomson J. A., Fitzgibbon M. J., Fleming M. A., Caron P. R., Hsiao K., and Navia M. A. (1995) X-ray structure of calcineurin inhibited by the immunophilin-immunosuppressant FKBP12-FK506 complex. Cell 82, 507-522.
57. Harding M. W., Galat A., Uehling D. E., and Schreiber S. L. (1989) A receptor for the immunosuppressant FK506 is a cis-trans peptidyl-prolyl isomerase. Nature 341, 758-760.
58. Hindley S., Juurlink B. H. J., Gusbers J. W., Middlemiss P. J., Herman M. A. R., and Rothbone M. P. (1997) Nitric oxide donors enhance neurotrophin-induced neurite outgrowth through a cGMP-dependent mechanism. J. Neurosci. Res. 47, 427-439.
59. Hodgkiss J. P. and Kelly J. S. (1995) Only "de novo" long-term depression (LTD) in the rat hippocampus in vitro is blocked by the same low concentration of FK506 that blocks LTD in the visual cortex. Brain Res. 705, 241-246.
60. Hoffman A. L., Makowka L., Banner B., Cai X., Cramer D. V., Pascualone A., Todo S., and Starzl T. E. (1990) The use of FK-506 for small intestine allotransplantation: inhibition of acute rejection and prevention of fatal graft-versus-host disease. Transplantation 49, 483-490.
61. Hol E., Gispen W. H., and Bär P. R. (1995) ACTH-related peptides: Receptors and signal transduction systems involved in their neurotrophic and neuroprotective actions. Peptides 16, 979-993.
62. Ide T., Morikawa E., and Kirino T. (1996) An immunosuppressant, FK506, protects hippocampal neurons from forebrain ischemia in the Mongolian gerbil. Neurosci. Lett. 204, 157-160.
63. Ikegami S., Kato A., Kudo Y., Kuno T., Ozawa F., and Inokuchi K. (1996) A facilitatory effect on the induction of long-term potentiation in vivo by chronic administration of antisense oligodeoxynucleotides against catalytic subunits of calcineurin. mol. Brain Res. 41, 183-191.
64. Itoh S., DeCenzo M. T., Livingston D. J., Pearlman D. A., and Navia M. A. (1995a) Conformation of FK506 in x-ray structures of its complexes with human recombinant FKBP12 mutants. Bioorganic Medicinal Chem. Lett. 5, 1983-1988.
65. Itoh S. and Navia M. A. (1995b) Structure comparison of native and mutant human recombinant FKBP12 complexes with the immunosuppressant drug FK506 (tacrolimus). Protein Sci. 4, 2261-2268.
66. Jones K. J. (1993) Gonadal steroids as promoting factors in axonal regeneration. Brain Res. Bull. 30, 491-498.
67. Joosten E. A. J., Verhaagh S., Martin D., Robe P., Franzen R., Hooiveld M., Doornbos R., Bär P. R., and Moonen G. (1996) Alpha-MSH stimulates neurite outgrowth of neonatal rat corticospinal neurons in vitro. Brain Res. 736, 91-98.
68. Kange M., Skottner A., Sjöberg J., and Lundborg G. (1989) Insulin-like growth factor I (IGF-I) stimulates regeneration of the rat sciatic nerve. Brain Res. 486, 396-398.
69. Kantor D. B., Lanzrein M., Stary S. J., Sandoval G. M., Smith W. B., Sullivan B. M., Davidson N., and Schuman E. M. (1996) A role for endothelial NO synthase in LTP revealed by adenovirus-mediated inhibition and rescue. Science 274, 1744-1748.
70. Kino T. and Goto T. (1993) Discovery of FK-506 and update. Ann. NY Acad. Sci. 685, 13-21.
71. Kino T., Hatanaka H., Hashimoto M., and Nishiyama H. (1987a) FK-506, a novel immunosuppressant isolated from a streptomyces. I. Fermentation, isolation, and physiochemical and biological characteristics. J. Antibiot. 40, 1249-1255.
72. Kino T., Hatanaka H., Miyata S., Inamura N., Nishiyama M., Yajima T., Goto T., Okuhara M., Kohsaka M., Aoki H., and Ochiai T. (1987b) FK-506, a novel immunosuppressant isolated from a streptomyces. II. Immunosuppressive effect of FK-506 in vitro. J. Antibiot. 40, 1256-1265.
73. Kitamura Y., Itano Y., Kubo T., and Nomura Y. (1994) Suppressive effect of FK-506, a novel immunosuppressant, against MPTP-induced dopamine depletion in the striatum of young C57BL/6 mice. J. Neuroimmunol. 50, 221-224.
74. Klee C. B. (1991) Concerted regulation of protein phosphorylation and dephosphorylation by calmodulin. Neurochem. Res. 16, 1059-1065.
75. Klintmalm G. (1994) The U.S. Multicenter FK 506 Liver Study Group: a comparison of tacrolimus (FK 506) and cyclosporine for immunosuppression in liver transplantation. N. Engl. J. Med. 331, 1110-1115.
76. Kralli A. and Yamamoto K. R. (1996) An FK506-sensitive transporter selectively decreases intracellular levels and potency of steroid hormones. J. Biol. Chem. 271, 17152-17156.
77. Kuromi H., Yoshihara M., and Kidokoro Y. (1997) An inhibitory role of calcineurin in endocytosis of synaptic vesicles at nerve terminals of Drosophila larvae. Neurosci. Res. 27, 101-113.
78. Ladner C. J., Czech J., Maurice J., Lorens S. A., and Lee J. M. (1996) Reduction of calcineurin enzymatic activity in Alzheimer's disease: correlation with neuropathologic changes. J. Neuropathol. Exp. Neurol 55, 924-931.
79. Landi G., D'Alessandro R. D., Dossi B. C., Ricci S., Simone I. L., and Ciccone A. (1993) Guillain-Barré syndrome after exogenous gangliosides in Italy. Brit. Med. J. 307, 1463-1464.
80. Lebeau M. C., Massol N., Herrick J., Faber L. E., Renoin M. J., Radanyi C., and Baulieu E. E. (1992) P59, an hsp 90-binding protein. Cloning and sequencing of its cDNA and preparation of a peptide-directed polyclonal antibody. J. Biol. Chem. 267, 4281-4284.
81. Letteron P., Fouin-Fortunet H., Tinel M., Danan G., Belghiti J., and Pessayre D. (1984) Mechanism for isaxonine hepatitis. I. Metabolic activation by mouse and human cytochrome P-450. J. Pharmacol. Exp. Ther. 229, 845-850.
82. Lewin G. R. (1995) Neurotrophic factors and pain. Neuroscience 7, 227-232.
83. Licitra E. J. and Liu J. O. (1996) A three-hybrid system for detecting small ligand-protein receptor interactions. Proc. Natl. Acad. Sci. USA 93, 12817-12821.
84. Lindholm D., Hengerer B., Zafra F., and Thoenen H. (1990) Transforming growth factor-β1 stimulates expression of nerve growth factor in the rat CNS. NeuroReport 1, 9-12.
85. Liu J., Farmer J. D., Lane W. S., Friedman J., Weissman I., and Schreiber S. L. (1991) Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell 66, 807-815.
86. Liu Y. and Storm D. R. (1990) Regulation of free calmodulin levels by neuromodulin: neuron growth and regeneration. Trends Pharmacol. Sci. 11, 107-111.
87. Lopez O. L., Martinez A. J., and Torre-Cisneros J. (1991) Neuropathologic findings in liver transplantation: a comparative study of cyclosporine and FK506. Transplant. Proc. 23 ,3181-3182.
88. Ludwin S. K. and Bisby M. A. (1992) Delayed Wallerian degeneration in the central nervous system of Ola mice: an ultrastructural study. J. Neurol. Sci. 109, 140-147.
89. Lyons W. E., Steiner J. P., Snyder S. H., and Dawson T. M. (1995) Neuronal regeneration enhances the expression of the immunophilin FKBP-12. J. Neurosci. 15, 2985-2994.
90. Lyons W. E., George E. B., Dawson T. M., Steiner J. P., and Snyder S. H. (1994) Immunosuppressant FK506 promotes neurite outgrowth in cultures of PC12 cells and sensory ganglia. Proc. Natl. Acad. Sci. USA 91, 3191-3195.
91. Lyons W. E., Steiner J. P., Dawson T. M., and Snyder S. H. (1992) Increased expression of FK-506 binding protein during peripheral nerve regeneration. Soc. Neurosci. Abstr. 18, 604.
92. Malen P. L. and Chapman P. F. (1997) Nitric oxide facilitates long-term potentiation, but not long-term depression. J. Neurosci. 17, 2645-2651.
93. Matsuura K., Kabuto H., Makino H., and Ogawa N. (1996) Cyclosporin A attenuates degeneration of dopaminergic neurons induced by 6-hydroxydopamine in the mouse brain. J. Neuroimmunol. 733, 101-104.
94. McDiarmid S. V., Busuttil R. W., Ascher N. L., Burdick A. J., D'Alessandro A. M., Esquivel C., Kalayoglu M., Klein A. S., Marsh J. W., Miller C. M., Schwartz M. E., Shaw B. W., and So S. K. (1995) FK506 (tacrolimus) compared with cyclosporine for primary immunosuppression after pediatric liver transplantation. Transplantation 59, 530-536.
95. Meiri K. F., Bickerstaff L. E., and Schwob J. E. (1991) Monoclonal antibodies show that kinase C phosphorylation of GAP-43 during axonogenesis is both spatially and temporally restricted in vivo. J. Cell Biol. 112, 991-1005.
96. Moriwaki A., Lu Y.-F., Hayashi Y., Tomizawa K., Tokuda M., Itano T., Hatase O., and Matsui H. (1996) Immunosuppressant FK506 prevents mossy fiber sprouting induced by kindling stimulation. Neurosci. Res. 25, 191-194.
97. Mueller A. R., Platz K.-P., Bechstein W,-O., Schattenfroh N., Stoltenburg-Didinger G., Blumhardt G., Christe W., and Neuhaus P. (1994) Neurotoxicity after orthotopic liver transplantation. A comparison between cyclosporine and FK506. Transplantation 58, 155-169.
98. Mukai H., Kuno T., Chang C-D., Lane B., Luly J. R., and Tanaka C. (1993) FKBP12-FK506 complex inhibits phosphatase activity of two mammalian isoforms of calcineurin irrespective of their substrates or activation mechanisms. J. Biochem. 113, 292-298.
99. Murad F. (1990) Drugs used for the treatment of angina: organic nitrates, calcium-channel blockers, and β-adrenergic antagonists, in Goodman and Gilman's: The Pharmacological Basis of Therapeutics (Gilman A. G., Rall T., Nies A. S., and Taylor P. eds.), Pergamon, New York, pp. 764-783.
100. Murase N., Todo S., Lee P.-H., Chapman F., Nalesnik M. A., Makowka L., and Starzl T. E. (1987) Heterotopic heart transplantation in the rat receiving FK-506 alone or with cyclosporine. Transplant. Proc. 19, 71-75.
101. Navia M. A. and Chaturvedi P. R. (1996) Design principles for orally bioavailable drugs. DDT 1, 179-189.
102. Neuhaus P., Pichlmayr R., and Williams R. (1994) The European FK 506 Multicentre Liver Study Group: randomised trial comparing tacrolimus (FK 506) and cyclosporin in prevention of liver allograft rejection. Lancet 344, 423-428.
103. Nozaki H., Tanaka K., Gomi S., Mihara B., Nogawa S., Nagata E., Kondo T., and Fukuuchi Y. (1996) Alteration of ryanodine receptor in the hippocampus CA1 after hemispheric cerebral ischemia. Neurochem. Res. 21, 975-982.
104. O'Dell T. J., Hawkins R. D., Kandel E. R., and Arancio O. (1991) Tests of the roles of two diffusible substances in long-term potentiation: evidence for nitric oxide as a possible early retrograde messenger. Proc. Natl. Acad. Sci. USA 88, 11285-11289.
105. Ochiai T., Sakamoto K., Nagata M., Nakajima K., Goto T., Hori S., Kenmochi T., Nakagori T., Asano T., and Isono K. (1988) Studies on FK-506 in experimental organ transplantation. Transplant. Proc. 20, 209-214.
106. Ochiai T., Nakajima K., Nagata M., Suzuki T., Asano T., Uematsu T., Goto T., Hori S., Kenmochi T., Nakagoori T., and Isono K. (1987) Effect of a new immunosuppressive agent, FK 506, on heterotopic cardiac allotransplantation in the rat. Transplant. Proc. 19, 1284-1286.
107. Odom A., Del Poeta M., Perfect J., and Heitman J. (1997) The immunosuppressant FK506 and its nonimmunosuppressive analog L-685,818 are toxic to Cryptococcus neoformans by inhibition of a common target protein. Antimicrob. Agents Chemother. 41, 156-161.
108. Owens-Grillo J. K., Hoffmann K., Hutchison K. A., Yem A. W., Deibel M. R., Jr., Handschumacher R. E., and Pratt W. B. (1995) The cyclosporin A-binding immunophilin CyP-40 and the FK506-binding immunophilin hsp56 bind to a common site on hsp90 and exist in independent cytosolic heterocomplexes with the untransformed glucocorticoid receptor. J. Biol. Chem. 270 ,20479-2048.
109. r of 63,000, 56,000, and 50,000. J. Biol. Chem. 266, 6708-6713.
110. Perry V. H., Brown M. C., Lunn E. R., Tree P., and Gordon S. (1990a) Evidence that very slow Wallerian degeneration in C57BL/Ola mice is an intrinsic property of the peripheral nerve. Eur. J. Neurosci. 2, 802-808.
111. Perry V. H., Lunn E. R., Brown M. C., Cahusac S., and Gordon S. (1990b) Evidence that the rate of Wallerian degeneration is controlled by a single autosomal dominant gene. Eur. J. Neurosci. 2, 408-413.
112. Ratajczak T. and Carrello A. (1996) Cyclophilin 40 (CyP-40), mapping of its hsp90 binding domain and evidence that FKBP52 competes with CyP-40 for hsp90 binding. J. Biol. Chem. 271, 2961-2965.
113. Roth G. A., Spada V., Hamill K., and Bornstein M. B. (1995) Insulin-like growth factor I increases myelination and inhibits demyelination in cultured organotypic nerve tissue. Dev. Brain Res. 88, 102-108.
114. Sakai K., Date I., Yoshimoto Y., Arisawa T., Nakashima H., Furuta T., Asari S., and Ohmoto T. (1991) The effect of a new immunosuppressive agent, FK-506, on xenogeneic neural transplantation in rodents. Brain Res. 565, 167-170.
115. Sanchez E. R. (1990) Hsp56: a novel heat shock protein associated with untransformed steroid receptor complexes. J. Biol. Chem. 265, 22067-22070.
116. Sanchez E. R. and Ning Y.-M. (1996) Immunophilins, heat shock protein, and glucocorticoid receptor actions in vivo. Meth. Enzymol. 9, 188-200.
117. Schonhofer P. S. (1991) Guillain-Barré syndrome and parenteral gangliosides. Lancet 338, 757.
118. Schreiber S. L. and Crabtree G. R. (1992) The mechanism of action of cyclosporin A and FK506. Immunol. Today 13, 136-142.
119. Schreiber S. L. (1991) Chemistry and biology of the immunophilins and their immunosuppressive ligands. Science 251, 283-287.
120. Schuman E. M. and Madison D. V. (1991) A requirement for the intercellular messenger nitric oxide in long-term potentiation. Science 254, 1503-1506.
121. Sebille A., Saint-André P., and Hugelin A. (1982) Acceleration by isaxonine of muscle reinnervation: electrophysiological demonstration in leprotic neuropathy. Nouv. Presse. Med. 11, 1278-1282.
122. Shapiro R., Fung J. J., Jain A. B., Parks P., Todo S., and Starzl T. E. (1990) The side effects of FK506 in humans. Tranplant. Proc. 22, 35-36.
123. Sharkey J. and Butcher S. P. (1994) Immunophilins mediate the neuroprotective effects of FK506 in focal cerebral ischaemia. Nature 371, 336-339.
124. Shibuki K. and Okada D. (1996) Endogenous nitric oxide release required for long-term synaptic depression in the cerebellum. Nature 349, 326-328.
125. Shuker S. B., Hajduk P. J., Meadows R. P., and Fesik S. W. (1996) Discovering high-affinity ligands for proteins: SAR by NMR. Science 274, 1531-1534.
126. Siekierka J. J., Wiederrecht G., Greulich H., Boulton D., Hung S. H. Y., Cryan J., Hodges P. J., and Sigal N. H. (1990) The cytosolic-binding protein for the immunosuppressant FK-506 is both a ubiquitous and highly conserved peptidyl-prolyl cis-trans isomerase. J. Biol. Chem. 265, 21011-21015.
127. Siekierka J. J., Hung S. H. Y., Poe M., Lin C. S., and Sigal N. H. (1989) A cytosolic binding protein for the immunosuppressant FK506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilin. Nature 341, 755-757.
128. Sigal N. H. and Dumont F. J. (1992) Cyclosporin A, FK-506, and rapamycin: pharmacologic probes of lymphocyte signal transduction. Annu. Rev. Immunol. 10, 519-560.
129. Sigal N. H., Dumont F., Durette P., Siekierka J. J., Peterson L., Rich D. H., Dunlap B. E., Staruch M. J., Melino M. R., Koprak S. L., Williams D., Witzel B., and Pisano J. M. (1991) Is cyclophilin involved in the immunosuppressive and nephrotoxic mechanism of action of cyclosporin A? J. Exp. Med. 173, 619-628.
130. Skene J. H. P. (1990) GAP-43 as a 'calmodulin sponge' and some implications for calcium signaling in axon terminals. Neurosci. Res. 13, S112-S125.
131. Skene J. H. P. (1989) Axonal growth-associated proteins. Annu. Rev. Neurosci. 12, 127-156.
132. Skene J. H. P. and Willard M. B. (1981a) Changes in axonally transported proteins during axon regeneration in toad retinal ganglion cells. J. Cell Biol. 89, 86-95.
133. Skene J. H. P. and Willard M. B. (1981b) Axonally transported proteins associated with growth in rabbit central and peripheral nervous system. J. Cell Biol. 89, 96-103.
134. Snyder S. H. and Sabatini D. M. (1995) Immunophilins and the nervous system. Nature Medicine 1, 32-37.
135. Sporel-Özakat R. E., Edwards P. M., Gerritsen van der Hoop G., and Gispen W. H. (1990) An ACTH(4-9) analog, Org 2766, improves recovery from acrylamide neuropathy in rats. Eur. J. Pharmacol. 186, 181-187.
136. Starr R., Hall F. L., and Moneiro M. J. (1996) A cdc2-like kinase distinct from cdk5 is associated with neurofilaments. J. Cell Sci. 109, 1565-1573.
137. Starzl T. E., Todo S., Fung J., Demetris A. J., Venkataramman R., and Jain A. (1989) FK-506 for liver, kidney, and pancreas transplantation. Lancet 2, 1000-1004.
138. Starzl T. E., Makowka L., and Todo S. (1987) FK-506: a potential breakthrough in immunosuppression. Transplant. Proc. 19, S3-S104.
139. Steiner J. P., Connolly M. A., Valentine H. L., Hamilton G. S., Dawson T. M., Hester L., and Snyder S. H. (1997a) Neurotrophic actions of non-immunosuppressive ligands of immunophilins. Nature Med. 3, 1-8.
140. Steiner J. P., Hamilton G. S., Ross D. T., Valentine H. L., Guo H., Connolly M. A., Liang S., Ramsey C., Li J., Huang W., Howorth P., Soni R., Fuller M., Sauer H., Nowotnik A. C., and Suzdak P. D. (1997b) Neurotrophic immunophilin ligands stimulate structural and functional recovery in neurodegenerative animal models. Proc. Natl. Acad. Sci. USA 94, 2019-2024.
141. Steiner J. P., Dawson T. M., Fotuhi M., and Snyder S. H. (1996) Immunophilin regulation of neurotransmitter release. Mol. Med. 96, 1076-1551.
142. Steiner J. P., Dawson T. M., Fotuhi M., Glatt C. E., Snowman A. M. M., Cohen N., and Snyder S. H. (1992) High brain densities of the immunophilin FKBP colocalized with calcineurin. Nature 358, 584-587.
143. Steiner J. P., Dawson T. M., Fotuhi C., Glatt C., Snowman A. M., Cohen N., and Snyder S. H. (1991) The immunosuppressant FK-506 enhances phosphorylation of GAP43: implications for a role in modulation of growth cone function and neurotransmitter release. Soc. Neurosci. Abstr. 18, 603.
144. Strand F. L. and Smith C. M. (1986) LPH, ACTH, MSH and motor systems, in Neuropeptides and Behavior (de Wied D., Gispen W. H., and van Wimersma Greidanus T. B., eds.), Pergamon, New York, pp. 245-272.
145. Strand F. L. and Kung T. T. (1980) ACTH accelerates recovery of neuromuscular function following crushing of peripheral nerve. Peptides 1, 135-138.
146. Sugawara T., Itoh Y., Mori E., Kojima H., and Kowada M. (1995) Immunosuppressive agents enhance regeneration of adult dorsal root axons into spinal cord. Soc. Neurosci. Abstr. 21, 315.
147. Tai P.-K., Albers M. W., Chang H., Faber L. E., and Schreiber S. L. (1992) Association of a 59-kilodalton immunophilin with the glucocorticoid receptor complex. Science 256, 1315-1318.
148. Takei K., Jay D. G., and Mikoshiba K. (1996) Regional laser inactivation of type 1 inositol 1,4,5 trisphosphate receptor affects growth cone morphology and motility in chick DRG neurons. Soc. Neurosci. Abstr. 22, 740.
149. Taniuchi M., Clark H. B., Schweitzer J. B., and Johnson E. M., Jr. (1988) Expression of nerve growth factor receptors by Schwann cells of axotomized peripheral nerves: ultrastructural location, suppression by axonal contact, and binding properties. J. Neurosci. 8, 664-681.
150. Terada N., Or R., Weinberg K., Domenico J., Lucas J. J., and Gelfand E. W. (1992) Transcription of IL-4 genes is not inhibited by cyclosporin A in competent T cells. J. Biol. Chem. 267, 21,207-21,210.
151. Timerman A. P., Ogunbumni E., Freund E., Wiederrecht G., Marks A. R., and Fleischer S. (1993) The calcium release channel of sarcoplasmic reticulum is modulated by FK-506-binding protein. J. Biol. Chem. 268, 22,992-22,999.
152. Tocci M. J., Matkovich D. A., Matkovich K., Collier K. A., Kwok P., Dumont F., Lin S., Degudicibus S., Siekerka J. J., Chin J., and Hutchinson N. I. (1989) The immunosuppressant FK506 selectively inhibits expression of early T cell activation genes. J. Immunol. 143, 718-726.
153. Todo S., Demetris A., Ueda Y., Imventarza O., Cadoff E., Zeevi A., and Starzl T. E. (1989) Renal transplantation in baboons under FK 506. Surgery 106, 444-451.
154. Todo S., Ueda Y., Demetris J. A., Imventarza O., Nalesnik M., Venkataramman R., Makowka L., and Starzl T. E. (1988) Immunosuppression of canine, monkey, and baboon allografts by FK 506: with special reference to synergism with other drugs and to tolerance induction. Surgery 104, 239-249.
155. Todo S., Podesta L., ChapChap P., Kahn D., Pan E.-E., Ueda Y., Okuda K., Imventarza O., Casavilla A., Demetris A. J., Makowka L., and Starzl T. E. (1987) Orthotopic liver transplantation in dogs receiving FK-506. Transplant. Proc. 19, S64-S67.
156. Tokime T., Nozaki K., and Kikuchi H. (1996) Neuroprotective effect of FK506, an immunosuppressant, on transient global ischemia in gerbil. Neurosci. Lett. 206, 81-84.
157. Tong G., Shepherd D., and Jahr C. E. (1995) Synaptic desensitization of NMDA receptors by calcineurin. Science 267, 1510-1512.
158. Torii N., Kamishita T., Otsu Y., and Tsumoto T. (1995) An inhibitor for calcineurin, FK506, blocks induction of long-term depression in rat visual cortex. Neuroscience 185, 1-4.
159. Vincenti F., Laskow D. A., Neylan J. F., Mendez R., and Matas A. J.
160. Walsh C. T., Zydowsky L. D., and McKeon F. D. (1992) Cyclosporin A, the cyclophilin class of peptidylprolyl isomerases, and blockade of T cell signal transduction. J. Biol. Chem. 267, 13,115-13,118.
161. Wang M. S., Zeleny-Pooley M., and Gold B. G. (1997) Comparative dose-dependency study of FK506 and cyclosporin A on the rate of axonal regeneration in rat sciatic nerve. J. Pharmacol. Exp. Ther. 282, 1084-1093.
162. Wang T., Li B.-y., Danielson P. D., Rockwell S., Lechleider R. J., Martin J., Manganaro T., and Donahoe P. K. (1996) The immunophilin FKBP12 functions as a common inhibitor of the TGFβ family type I receptors. Cell 86, 435-444.
163. Wang T., Donahoe P. K., and Zervos A. S. (1994) Specific interaction of type I receptors of the TGF-β family with the immunophilin FKBP-12. Science 265, 674-676.
164. Wayne D. B. and Skene J. H. P. (1995) Endogenous nitric oxide modulates neurite growth in regenerating rat sensory neurons. Soc. Neurosci. Abstr. 21, 1292.
165. Wiederrect G. and Etzkorn F. (1995) The immunophilins. Perspectives Drug Discovery Design 2, 57-84.
166. Wiederrecht G., Lam E., Hung S., Martin M., and Sigal N. (1993) The mechanism of action of FK-506 and cyclosporin A. Ann. NY Acad. Sci. 696, 9-19.
167. Wiederrecht G., Hung S., Chan H. K., Marcy A., Martin M., Calaycay J., Boulton D., Sigal N., Kincaid R. L., and Siekierka J. J. (1992) Characterization of high molecular weight FK-506 binding activities reveals a novel FK-506-binding protein as well as a protein complex. J. Biol. Chem. 267, 21,753-21,760.
168. Wijdicks E. F. M., Weisner R. H., Dahlke L. J., and Krom R. A. F. (1994) FK506-induced neurotoxicity in liver transplantation. Ann. Neurol. 35, 498-501.
169. Yagita Y., Kitagawa K., Matsushita K., Taguchi A., Mabuchi T., Ohtsuki T., Yanagihara T., and Matsumoto M. (1996) Effect of immunosuppressant FK506 on ischemia-induced degeneration of hippocampal neurons in gerbils. Life Sci. 59, 1643-1650.
170. Yao G. L. and Kiyama H. (1995) Dexamethasone enhances level of GAP-43 mRNA after nerve injury and facilitates re-projection of the hypoglossal nerve. Mol. Brain Res. 32, 308-312.